Filings
Trends
Rankings
Learn
Home
/
Flagship Pioneering, LLC
/
Q4 2025 Filing
Flagship Pioneering, LLC
Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$324.0M
Holdings
4
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (4 positions)
#
Stock
Shares
Value
% Portfolio
Type
1
MRNA
Moderna Inc
4,632,149
$136.6M
42.16%
2
SANA
Sana Biotechnology Inc
25,001,856
$101.8M
31.40%
3
FHTX
Foghorn Therapeutics Inc
12,674,120
$68.4M
21.12%
4
MCRB
Seres Therapeutics Inc
1,155,850
$17.2M
5.32%